[1] Singer M,Deutschman C S,Seymour C W, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA,2016,315(8):801
[2] Cheng B, Xie G, Yao S, et al. Epidemiology of sever sepsis in critically ill surgical patients in ten university hospitals in China[J]. Crit Care Med, 2007, 35(11): 2538
[3] Okwor I,Onyilagha C,Kuriakose S, et al. Regulatory T cells enhance susceptibility to experimental Trypanosomacongolense infection Independent of mouse genetic background[J]. PLoS Negl Trop Dis,2012,6(7):1761
[4] Nascimento D C,Alves-Filho J C,S?觝nego F, et al. Role of regulatory T cells in long-term immune dysfunction associated with severe sepsis[J]. Crit Care Med,2010,38(8):1718
[5] Dellinger R P,Levy M M,Carlet J M, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008[J]. Intensive Care Med,2008,34(1):17
[6] Deutschman C S,Tracey K J. Sepsis: current dogma and new perspectives[J]. Immunity,2014,40(4):463
[7] BernardA M,Bernard G R. The immune response: targets for the treatment of severe sepsis[J]. Int J Inflam,2012:697592
[8] Fernandez R,Nardocci G,Navarro C, et al. Neural reflex regulation of systemic inflammation: potential new targets for sepsis therapy[J].Front Physiol,2014,5:489
[9] Markwart R,Condotta S A,Requardt R P, et al. Immunosuppression after sepsis: systemic inflammation and sepsis induce a loss of na?觙ve T-cells but no enduring cell-autonomous defects in T-cell function[J]. PLoS One,2014,9(12):e115094
[10] Rittirsch D,Huber-Lang M S,Flierl M A, et al. Immunodesign of experimental sepsis by cecal ligation and puncture[J]. Nat Protoc,2009,4(1):31
[11] Yang J,Zhang J X,WangH,et al. Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling[J].World J Gastroenterol,2012,18(23):2938-2947.
[12] Huss D J,Pellerin A F,Collette B P,et al. Anti-CD25 monoclonal antibody Fc variants differentially impact Treg cells and immune homeostasis[J]. Immunology,2016.
[13] Doyle SL,O’Neil LA. Toll-like receptors:From the discovery of NF-κB to new insights into transcriptional regulations in innate immunity[J]. Biochem Pharmacol,2006,72(9):1102
[14] Li T,Hu J,Thomas J A,et al.Differential induction of apoptosis by LPS and taxol in monocytic cells[J].Mol Immunol,2005,42(9):1049
[15] Akira S,Takeda K.Toll-like receotorsignaling[J]. Nat Rev Immunol,2004,4(7):499
[16] Zou L,Feng Y,Li Y, et al. Complement factor B is the downstream effector of TLRs and plays an important role in a mouse model of severe sepsis[J]. J Immunol,2013,191(11):5625
[17] Nagai Y,Akashi S,Nagafuku M, et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution[J]. Nat Immunol,2002,3(7):667
[18] Muroi M,Ohnishi T,Tanamoto K I. Regions of the mouse CD14 molecule required for toll-like receptor 2- and 4-mediated activation of NF-kappa B[J]. J Biol Chem,2002,277(44):42372
[19] Sharma S,Tenoever B R,Grandvaux N, et al. Triggering the interferon antiviral response through an IKK-related pathway[J]. Science,2003,300(5622):1148
[20] 申鹏霄,王建生.雷米普利对阿霉素肾病大鼠肾脏Toll样受体4,核因子-κB,白细胞介素-8表达的影响[J].中华实用诊断与治疗杂志,2010,24(3):250
[21] 司徒超,黄卫东,付秀丽,等.脓毒症患儿白细胞介素-6、血小板动态测定的临床意义[J].中华实用诊断与治疗杂志,2009,23(12):1202
[1]杨 扬,杨 洁.丹参酮ⅡA对EAE小鼠临床表现及外周Treg细胞的影响[J].天津医科大学学报,2017,23(01):17.
YANG Yang,YANG Jie.Effects of TanshinonⅡA on the clinical manifestation and peripheral Treg of EAE mice[J].Journal of Tianjin Medical University,2017,23(06):17.
[2]杨武霞,王爱迪,王梦晓 综述,等.树突状细胞调控T细胞免疫在免疫性血小板减少症中的研究进展[J].天津医科大学学报,2022,28(04):445.
[3]来佳丹,魏诗瑶,李常颖.肾癌来源的IL4I1介导Treg诱导与募集的实验研究[J].天津医科大学学报,2023,29(03):302.
LAI Jia-dan,WEI Shi-yao,LI Chang-ying.Research on inducement and recruitment of Treg mediated by IL4I1 derived from renal cell carcinoma[J].Journal of Tianjin Medical University,2023,29(06):302.